High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

Progress in development of prognostic and therapeutic options for the rare cholestatic liver diseases, primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), is hampered by limited knowledge of their pathogeneses. In particular, the potential role of hepatotoxic and/or metabolis...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Douglas I., Juran, Brian D., Cheung, Angela C., Schlicht, Erik M., Liang, Yongliang, Niedzwiecki, Megan, LaRusso, Nicholas F., Gores, Gregory J., Jones, Dean P., Miller, Gary W., Lazaridis, Konstantinos N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035559/
https://www.ncbi.nlm.nih.gov/pubmed/34825528
http://dx.doi.org/10.1002/hep4.1871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035559/
https://www.ncbi.nlm.nih.gov/pubmed/34825528
http://dx.doi.org/10.1002/hep4.1871

Ejemplares similares